We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Cardiology

Cancer and Heart Failure in Scotland: Epidemiology, Interactions, and Prognostic Implications

MedXY Editorial Team•Jun 24, 2026•Cardiology
cancerepidemiologyheart failureprognosis

Highlights

  • Patients with an expanded definition of heart failure (HFexp) exhibit a modest but significant increase in cancer incidence, varying by cancer type.
  • Coexistence of cancer and heart failure markedly worsens prognosis, with similar contributions from cardiovascular and cancer-related mortality.
  • Cardio-oncology evidence emphasizes the importance of early cardiac monitoring and vigilant management in cancer survivors and patients undergoing cardiotoxic therapies.
  • Emerging therapeutic and prophylactic strategies, including antihypertensive agents and novel heart failure treatments, show potential to mitigate cardiotoxicity and improve outcomes.

Background

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Unraveling Assortative Mating: How Parental Similarity Shapes Psychiatric Disorder Heritability and Prevalence at the Population LevelA large Danish cohort study reveals that partner similarity for psychiatric disorders significantly inflates both prevalence and heritability estimates, highlighting important public health and genetic counseling implications.Sep 27, 2026Unraveling the Clinical Complexity of Extremely High NT-proBNP in Hospitalized Adults: Beyond Heart FailureExtremely high NT-proBNP levels in hospitalized patients often indicate infection rather than heart failure, with a high mortality risk; interpretation requires comprehensive clinical context.Sep 27, 2026Soluble BCMA as a Key Biomarker Defining Tumor Phenotypes and Prognosis in Newly Diagnosed Multiple MyelomaSoluble BCMA levels in newly diagnosed multiple myeloma patients reveal distinct tumor phenotypes and predict prognosis more strongly than tumor volume, enabling improved risk stratification and clinical decision-making.Sep 27, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Cardiac Resynchronization Therapy With or Without Atrioventricular Node Ablation in Atrial Fibrillation: The CAAN-AF Trial
This trial evaluated whether atrioventricular node ablation improves outcomes of cardiac resynchronization therapy in heart failure patients with permanent atrial fibrillation, finding no significant benefit over medical rate control.
Sep 25, 2026
Enhancing Prognosis in Stable Coronary Artery Disease: Insights from a Nationwide Cohort on FFR-CTThis large nationwide study demonstrates that coronary CTA-derived FFR-CT strongly predicts future myocardial infarction, cardiovascular death, and revascularization, independent of traditional risk factors and stenosis severity, with a thrSep 25, 2026
Rising Prevalence of Non-Cystic Fibrosis Bronchiectasis in US Primary Care: Insights from a Decade of Electronic Health RecordsBetween 2015 and 2025, non-cystic fibrosis bronchiectasis prevalence in the US primary care population increased by 133%, predominantly affecting older, white, female patients with Medicare coverage.Sep 25, 2026